Stock Traders Buy High Volume of Teladoc Health Call Options (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) was the recipient of unusually large options trading on Thursday. Stock traders purchased 33,742 call options on the company. This represents an increase of approximately 66% compared to the average volume of 20,354 call options.

Teladoc Health Price Performance

Teladoc Health stock opened at $9.37 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a one year low of $6.76 and a one year high of $15.95. The company has a market cap of $1.63 billion, a P/E ratio of -1.62 and a beta of 1.27. The business has a fifty day moving average of $10.62 and a two-hundred day moving average of $9.62.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. As a group, analysts predict that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on TDOC shares. Royal Bank of Canada raised their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Bank of America raised their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. Oppenheimer reduced their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th. The Goldman Sachs Group lowered their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a report on Monday. Finally, Piper Sandler reduced their price objective on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Eleven analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $11.26.

Institutional Investors Weigh In On Teladoc Health

Institutional investors and hedge funds have recently modified their holdings of the company. Versant Capital Management Inc boosted its position in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after purchasing an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC acquired a new position in shares of Teladoc Health during the 4th quarter worth $29,000. Lindbrook Capital LLC boosted its position in shares of Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after buying an additional 1,612 shares in the last quarter. Sterling Capital Management LLC grew its stake in Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock valued at $42,000 after acquiring an additional 4,101 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd purchased a new position in Teladoc Health during the 4th quarter valued at about $60,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.